All posts tagged
French CAR-T Company Halts Clinical Trials Because of a Patient Death
Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks
French Biotech gets an EU CRISPR Patent for CAR-T Research
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
Which EU Immuno-Oncology Company are you Cheering for?
The Most Important Battle in Gene Editing: CRISPR versus TALEN
How is Biotech Transforming Pharma’s R&D Model?
“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”
What are the Best Countries to Recruit Biotech Talents in 2017?
CAR-T Competition Heats Up with a New IND Approval
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
Labiotech UG, All Rights Reserved -
Send this to a friend